PET en el diagnóstico de la patología de tiroides

  1. Luis Gonzaga DÍAZ-GONZÁLEZ 1
  2. Paloma GARCÍA-TALAVERA 1
  3. Felipe GÓMEZ-CAMINERO 1
  4. Cristina RIOLA-PARADA 1
  5. Juan Gabriel VILLANUEVA-CURTO 1
  6. Pilar TAMAYO-ALONSO 1
  1. 1 Hospital Universitario de Salalamanca
Journal:
Revista ORL

ISSN: 2444-7986,  2444-7986

Year of publication: 2020

Volume: 11

Volume: 3

Pages: 297-304

Type: Article

DOI: 10.14201/ORL.21520 DIALNET GOOGLE SCHOLAR lock_openDialnet editor

More publications in: Revista ORL

Abstract

Introduction and objective: PET/CT is a technique which oncological indications are now increasing, being thyroid cancer one of them. Method: narrative review. Comment: The present study is a review of well-known indications, as well as those fields in which more studies are needed to establish the utility of this technique in every kind of malignant thyroid pathology.

Bibliographic References

  • Basu S, Kumar R, Ranade R. Assessment of treatment response using PET. PET Clin. 2015; 10(1):9-26.
  • Deandreis D, Al Ghuzlan A, Auperin A, Vielh P, Caillou B, Chami L, et al. Is (18)F-fluorodeoxyglucose- PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology? Thyroid. 2012; 22(2):165-72.
  • Feine U, Lietzenmayer R, Hanke JP, Wohrle H, Muller-Schauenburg W. [18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I]. Nuklearmedizin. 1995; 34(4):127-34.
  • Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016; 26(1):1-133.
  • Jang HW, Choi JY, Lee JI, Kim HK, Shin HW, Shin JH, et al. Localization of medullary thyroid carcinoma after surgery using (11)C-methionine PET/CT: comparison with (18)F-FDG PET/CT. Endocr J. 2010; 57(12):1045-54.
  • Kloos RT. Approach to the patient with a positive serum thyroglobulin and a negative radioiodine scan after initial therapy for differentiated thyroid cancer. J Clin Endocrinol Metab. 2008; 93(5):1519-25.
  • Kushchayev SV, Kushchayeva YS, Tella SH, Glushko T, Pacak K, Teytelboym OM. Medullary Thyroid Carcinoma: An Update on Imaging. J Thyroid Res. 2019; 2019:1893047.
  • Marcus C, Whitworth PW, Surasi DS, Pai SI, Subramaniam RM. PET/CT in the management of thyroid cancers. AJR Am J Roentgenol. 2014; 202(6):1316-29.
  • Muros de Fuentes MA, Mitjavila Casanovas M, Estorch Cabrera M, Lecumberri Santamaria B, Navarro Gonzalez E. Usefulness of 18F-FDG PET/CT in thyroid carcinoma. Rev Esp Med Nucl Imagen Mol. 2016; 35(3):186-92.
  • Nascimento C, Borget I, Al Ghuzlan A, Deandreis D, Hartl D, Lumbroso J, et al. Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer. Thyroid. 2015; 25(4):437-44.
  • Riola-Parada C, Garcia-Canamaque L, Perez- Duenas V, Garcerant-Tafur M, Carreras-Delgado JL. Simultaneous PET/MRI vs PET/CT in oncology. A systematic review. Rev Esp Med Nucl Imagen Mol. 2016; 35(5):306-12.
  • Skoura E. Depicting medullary thyroid cancer recurrence: the past and the future of nuclear medicine imaging. Int J Endocrinol Metab. 2013; 11(4):e8156.
  • Treglia G, Annunziata S, Muoio B, Salvatori M, Ceriani L, Giovanella L. The role of fluorine- 18-fluorodeoxyglucose positron emission tomography in aggressive histological subtypes of thyroid cancer: an overview. Int J Endocrinol. 2013; 2013:856189.
  • Treglia G, Cocciolillo F, Di Nardo F, Poscia A, de Waure C, Giordano A, et al. Detection rate of recurrent medullary thyroid carcinoma using fluorine- 18 dihydroxyphenylalanine positron emission tomography: a meta-analysis. Acad Radiol. 2012; 19(10):1290-9.
  • Treglia G, Tamburello A, Giovanella L. Detection rate of somatostatin receptor PET in patients with recurrent medullary thyroid carcinoma: a systematic review and a meta-analysis. Hormones (Athens). 2017; 16(4):362-72.
Data source: Dialnet